![Alan Glicklich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alan Glicklich
Direktor/Vorstandsmitglied bei
CALCIMEDICA, INC.
Vermögen: - $ am 30.06.2026
Profil
Alan Glicklich is an Independent Director at CalciMedica, Inc. since 2025.
Former positions include Vice President-Clinical Affairs at Savient Pharmaceuticals, Inc. in 2013, Vice President-Clinical Development at Arena Pharmaceuticals, Inc. from 2014 to 2015, Chief Medical Officer at Bird Rock Bio Sub, Inc. from 2015 to 2020, Vice President-Clinical Affairs at Veloxis Pharmaceuticals, Inc., and Chief Medical Officer at Chinook Therapeutics, Inc. from 2020 to 2022.
Education includes an MBA from Emory University, an undergraduate degree from The University of Chicago, and a doctorate from the University of Wisconsin.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CALCIMEDICA, INC. -.--% | 31.03.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktive Positionen von Alan Glicklich
| Unternehmen | Position | Beginn |
|---|---|---|
| CALCIMEDICA, INC. | Direktor/Vorstandsmitglied | 15.01.2025 |
Ehemalige bekannte Positionen von Alan Glicklich
| Unternehmen | Position | Ende |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 11.02.2022 |
Bird Rock Bio Sub, Inc.
 Bird Rock Bio Sub, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2020 |
| ARENA PHARMACEUTICALS | Corporate Officer/Principal | 01.09.2015 |
| SAVIENT PHARMACEUTICALS INC | Corporate Officer/Principal | 01.10.2013 |
Veloxis Pharmaceuticals, Inc.
 Veloxis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for kidney transplant patients | Corporate Officer/Principal | - |
Ausbildung von Alan Glicklich
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
8
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Emory University
 Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bird Rock Bio Sub, Inc.
Bird Rock Bio Sub, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Veloxis Pharmaceuticals, Inc.
Veloxis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for kidney transplant patients | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes medicines for kidney diseases | Health Technology |
CalciMedica, Inc.
 CalciMedica, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Wählen Sie MarketScreener 
